Single cycle induction treatment with cisplatin/docetaxel plus durvalumab/tremelimumab in stage III-IVB head and neck squamous cell cancer (CheckRad-CD8 trial)

Hecht M, Gostian AO, Eckstein M, Rutzner S, Von Der Gruen J, Illmer T, Hautmann MG, Brunner T, Laban S, Klautke G, Tamaskovics B, Frey B, Hartmann A, Roedel C, Budach W, Gaipl U, Iro H, Fietkau R (2019)


Publication Type: Conference contribution

Publication year: 2019

Journal

Publisher: OXFORD UNIV PRESS

City/Town: OXFORD

Conference Proceedings Title: ANNALS OF ONCOLOGY

Event location: Barcelona ES

DOI: 10.1093/annonc/mdz252.016

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Hecht, M., Gostian, A.-O., Eckstein, M., Rutzner, S., Von Der Gruen, J., Illmer, T.,... Fietkau, R. (2019). Single cycle induction treatment with cisplatin/docetaxel plus durvalumab/tremelimumab in stage III-IVB head and neck squamous cell cancer (CheckRad-CD8 trial). In ANNALS OF ONCOLOGY. Barcelona, ES: OXFORD: OXFORD UNIV PRESS.

MLA:

Hecht, Markus, et al. "Single cycle induction treatment with cisplatin/docetaxel plus durvalumab/tremelimumab in stage III-IVB head and neck squamous cell cancer (CheckRad-CD8 trial)." Proceedings of the 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona OXFORD: OXFORD UNIV PRESS, 2019.

BibTeX: Download